DIRAZEC Trademark

Trademark Overview


On Friday, August 22, 2008, a trademark application was filed for DIRAZEC with the United States Patent and Trademark Office. The USPTO has given the DIRAZEC trademark a serial number of 79060357. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Wednesday, August 22, 2018. This trademark is owned by Astellas Pharma Inc.. The DIRAZEC trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations as an anti-cancer drug for human use
dirazec

General Information


Serial Number79060357
Word MarkDIRAZEC
Filing DateFriday, August 22, 2008
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateWednesday, August 22, 2018
Registration Number3598818
Registration DateTuesday, March 31, 2009
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, January 13, 2009

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesPharmaceutical preparations as an anti-cancer drug for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, November 6, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCelgene Corporation
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressUS

Party NameAstellas Pharma Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJP

Party NameAstellas Pharma Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP

Party NameAstellas Pharma Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events


Event DateEvent Description
Friday, March 22, 2019NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, March 22, 2019DEATH OF INTERNATIONAL REGISTRATION
Friday, April 21, 2017TOTAL INVALIDATION PROCESSED BY THE IB
Friday, July 8, 2016TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Friday, July 8, 2016INVALIDATION PROCESSED
Wednesday, July 6, 2016TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, November 6, 2015CANCELLED SECTION 71
Thursday, September 10, 2015NEW REPRESENTATIVE AT IB RECEIVED
Thursday, May 12, 2011CHANGE OF OWNER RECEIVED FROM IB
Tuesday, March 31, 2009REGISTERED-PRINCIPAL REGISTER
Tuesday, January 13, 2009PUBLISHED FOR OPPOSITION
Wednesday, December 24, 2008NOTICE OF PUBLICATION
Wednesday, December 10, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, December 10, 2008ASSIGNED TO LIE
Wednesday, December 3, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 2, 2008ASSIGNED TO EXAMINER
Tuesday, November 18, 2008APPLICATION FILING RECEIPT MAILED
Friday, November 14, 2008NEW APPLICATION ENTERED IN TRAM
Thursday, November 13, 2008SN ASSIGNED FOR SECT 66A APPL FROM IB